| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aura Biosciences, Inc. (AURA) has 9 insiders with recent SEC Form 4 filings, including 7 buys and 8 sells. AURA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 457.5K | $3.67M | - | |
| Other | 252.7K | $2.03M | - | |
| Other | 217.8K | $1.75M | -11,738 | |
| Other | 206.9K | $1.66M | - | |
| Other | 197.3K | $1.58M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | De Los Pinos Elisabet73 | See Remarks | Sell | 9,200 | $10.74 | $98,787.76 | -2.8% | -25.4% | -42.7% | |
| Oct 29, 2024 | Elazzouzi Amy74 | Vice President, Finance | Sell | 553 | $10.74 | $5,938.39 | -1.4% | -25.4% | -42.7% | |
| Oct 18, 2024 | Feder Julie B60 | Chief Financial Officer | Sale+OE | 25,131 | $12.03 | $302,361.11 | -15.8% | -34.7% | -51.7% | |
| Oct 18, 2024 | De Los Pinos Elisabet73 | See Remarks | Sale+OE | 24,992 | $12.04 | $300,838.70 | -7.0% | -34.7% | -51.7% | |
| Oct 16, 2024 | Plavsic Mark76 | Chief Technology Officer | Sell | 7,383 | $9.85 | $72,722.55 | -5.7% | -26.2% | -39.6% | |
| Jan 23, 2024 | De Los Pinos Elisabet73 | See Remarks | Sell | 15,853 | $7.64 | $121,140.70 | -8.9% | -7.2% | +3.8% | |
| Jan 23, 2024 | Feder Julie B60 | Chief Financial Officer | Sell | 6,609 | $7.64 | $50,521.18 | -9.5% | -7.2% | +3.8% | |
| Nov 9, 2023 | Matrix Capital Management Company, LP | 10% Owner | Buy | 1,560,000 | $9.00 | $14,040,000.00 | +29.1% | +14.0% | +55.0% | |
| Nov 8, 2023 | Johnson David Michael58 | Director | Buy | 199,601 | $7.19 | $1,434,987.30 | +58.3% | +11.3% | +48.9% | |
| Nov 6, 2023 | Feder Julie B60 | Chief Financial Officer | Sale+OE | 3,900 | $12.07 | $47,053.89 | -5.3% | -29.4% | -6.5% |